Hyperlipidemia Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GLMD | D | Galmed Pharmaceuticals Ltd. | -1.65 | |
MDGL | D | Madrigal Pharmaceuticals, Inc. | 2.82 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SURI | D | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 5.62 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 2.25 | |
XBI | D | SPDR S&P Biotech ETF | 1.03 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 1.02 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.8 |
Compare ETFs
- Hyperlipidemia
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels).
Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
Hyperlipidemias are divided into primary and secondary subtypes. Primary hyperlipidemia is usually due to genetic causes (such as a mutation in a receptor protein), while secondary hyperlipidemia arises due to other underlying causes such as diabetes. Lipid and lipoprotein abnormalities are common in the general population and are regarded as modifiable risk factors for cardiovascular disease due to their influence on atherosclerosis. In addition, some forms may predispose to acute pancreatitis.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles